Pandemic influenza virus split vaccine (Chengdu Kanghua Biological)

大流行流感裂解疫苗（康华生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePandemic influenza virus split vaccine (Chengdu Kanghua Biological)

Drug Alias NameSplit virion influenza vaccine - Chengdu Kanghua Biological Products

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (IND)

Highest Status in ChinaPending

Originator CompaniesChengdu Kanghua Biological Products Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesChengdu Kanghua Biological Products Co Ltd

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A